How personalized medicine became genetic, and racial: Werner kalow and the formations of pharmacogenetics

Journal of the History of Medicine and Allied Sciences

Volumn 68, Issue 1, 2013, Pages 1-48

  Jones, David S ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

genetics; molecular biology; pharmacogenetics; pharmacology; race; Werner Kalow

Indexed keywords

ARTICLE; HISTORY; HUMAN; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHARMACOLOGY; RACE;

CONTINENTAL POPULATION GROUPS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INDIVIDUALIZED MEDICINE; PHARMACOGENETICS; PHARMACOLOGY;

EID: 84871343391     PISSN: 00225045     EISSN: 14684373     Source Type: Journal    
DOI: 10.1093/jhmas/jrr046     Document Type: Article

References (8)

1. Werner Kalow, Pharmacogenetics: Heredity and the Response to Drugs (Philadelphia: W.W. Saunders Company, 1962).
2. H. M. Schmeck, "Heredity Linked to Drug Effects," New York Times, 10 October 1962, 96
3. Harry Marks, "Making Risks Visible: The Science &Politics of Adverse Drug Reactions," in Ways of Regulating: Therapeutic Agents between Plants, Shops, and Consulting Rooms, ed. Jean Paul Gaudillière and Volker Hess (Berlin: Max-Planck-Institute für Wissenschaftsgeschichte, Preprint 363, 2009), 105-22.
4. Margaret A. Hamburg and Francis S. Collins, "The Path to Personalized Medicine," N. Engl. J. Med., 2010, 363, 301-4.
5. G. C. Bowker and S. L. Star, Sorting Things Out: Classification and Its Consequences (Cambridge: MIT Press, 1999).
6. I. Hacking, "The Looping Effect of Human Kinds," in D. Sperber, D. Premack, and A. J. Premac, eds., Causal Cognition: An Interdisciplinary Approach (Oxford: Oxford University Press, 1995).
7. H. L. Behforouz, P. E. Farmer, and J. Mukherjee, "From Directly Observed Therapy to Accompagnateurs: Enhancing AIDS Treatment Outcomes in Haiti and in Boston," Clin. Infect. Dis., 2004, 38, Suppl. 5, S429-S436.
8. N. Wade, "Decades Later, Genetic Map Yields Few Cures," New York Times, 12 June 2010.